Published by Communications and Public Affairs (519) 824-4120, Ext. 56982 or 53338
June 24, 2005
Renowned Cancer Researcher to Deliver Chappel Lecture
One of the world’s leading cancer researchers will deliver the 2005 Chappel Memorial Lecture June 30 at the Ontario Veterinary College.
Dr. Robert Kerbel, a senior scientist in molecular and cellular biology research at the Sunnybrook and Women’s College Health Sciences Centre and a professor of laboratory medicine and pathobiology at the University of Toronto, will speak at 1:30 p.m. in Room 1714 of the OVC Lifetime Learning Centre.
His lecture, “Anti-angiogenic Metronomic Chemotherapy for Cancer: From Bench to Bedside and Back,” is open to everyone.
Kerbel’s research focuses on the biology of cancer. In particular, he has studied the ways in which malignant tumours interact with blood vessels and other tissues: how they develop, grow and metastasize and how to stop or delay such processes.
Over the last 25 years, he has made a number of seminal contributions to the field, most notably in anti-angiogenic therapy, in which he is recognized as one of the world’s pioneers and leading investigators. The therapy involves frequent low-dose “metronomic” chemotherapy as a relatively non-toxic way to slow the progress of tumours by targeting their blood supply.
The author of 269 publications, Kerbel has earned several prestigious honours, including the 2004 Robert L. Noble Prize from the National Cancer Institute of Canada and a seven-year Tier-1 Canada Research Chair in molecular biology.
The annual Chappel Lecture was established by 1950 OVC graduate Clifford Chappel in memory of his father, Herbert James Chappel, to give students and faculty the opportunity to meet internationally known scientists.
For media questions, contact Barry Gunn, OVC communications officer, (519) 824-4120, Ext. 54414.